Skip to main content

Our Indications

Therapy Areas and Indications of the Studies Conducted By Us

In the following indications we have already conducted pharmaceutical studies of phases I to IV as well as medical device studies:

Therapy AreaIndicationDrug StudyDevice Study
CardiologyDyslipidemiaPhase III
CardiologyHeart FailurePhase II
CardiologyHeart InsufficiencyPhase III
CardiologyArteriosclerosisPhase III
CardiologyEmbolic Stroke
Cardiology Acute Myocardial Infarction
CardiologyAcute Coronary SyndromePhase III
CardiologyAngioplasty
PulmonologyAsthmaPhase II, III + IV
NeurologyAlzheimer’s DiseasePhase II
NeurologyChronic Inflammatory Demyelinating PolyneuropathyPhase III
NeurologyMultiple SclerosisPhase III
NeurologyMigrainePhase II
GynecologyEstrogen Replacement Therapy in MenopausePhase IV
GastroenterologyOesophageal Reflux DiseasePhase III
InfectiologyStaphylococcus aureusPhase II
InfectiologyHIV ImmunizationPhase II
InfectiologyChronic Diarrhea in AIDS PatientsPhase III
InfectiologyAcute PancreatitisPhase III
NephrologyAnaemiaPhase IV
RheumatologyRheumatic ArthritisPhase I
OphthalmologyMacular DegenerationPhase IV
DermatologyAtopic DermatitisPhase Ib
DermatologyPsoriasisPhase IIa + III
DermatologyRosaceaPhase I
DermatologyHair LossConsumer Product
DermatologyMalar Volume Augmentation
DermatologyLaser Therapy + Cryosurgery of Clavus Durus
EndocrinologyAcromegaly,  Diabetic RetinopathyPhase I
EndocrinologyGrowth Hormone DeficiencyPhase IIIb
EpidemiologyNew Influenza (H1N1)Phase IV
OncologyMultiple MyelomaPhase II/III
OncologyMalignant MelanomaPhase IV
OncologyHead and Neck CarcinomaPhase II + III
OncologyMamma CarcinomaPhase III
OncologyNon-Hodgkin-LymphomaPhase III
OncologyNon-Small Cell Lung CarcinomaPhase II + III
OncologyActinic KeratosisPhase IV
OncologyAcute Lymphatic LeukemiaPhase III